ARRAY BIOPHARMA INC - 04269X105
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Byrne Asset Management LLC | History | New | 500 | 4 | 0.0% | — | 1 | +500 | New | Q3 2025 | Oct 22, 2025 |
| CIBC WORLD MARKETS CORP | History | Closed out | 0 | 0 | — | 0.0% | — | -33,888 | -100.0% | Q1 2025 | May 13, 2025 |